|
síntomas respiratorios. Se prescribe Sulfasalazina y corticosteroides con resolución rápida de síntomas intestinales y de la opacidad pulmonar mencionada.
Describimos la presentación clínica de un varón con diagnóstico
reciente de enfermedad de Crohn en quien se encontró una lesión
pulmonar asintomática en estudios imagenológicos. Las
complicaciones pulmonares en enfermedad inflamatoria intestinal ha
sido descritas previamente, siendo más comunes en colitis
ulcerativa que en enfermedad de Crohn. Estas pueden comprometer el
parénquima pulmonar, el árbol bronquial y la pleura. La
prevalencia y etiología de éstas lesiones son aún desconocidas,
y no se asocian necesariamente a actividad de enfermedad. Se ha
reportado anormalidades en las pruebas de función respiratoria
durante exacerbaciones de enfermedad inflamatoria intestinal, y si
bien los hallazgos pulmonares pueden presentarse con una
diversidad de síntomas, las presentaciones subclínicas se han
descrito también. Las manifestaciones pulmonares responden
generalmente a corticosteroides, como fue el caso en nuestro
paciente.
SUMMARY
40 year-old male recently diagnosed with Crohn’s disease. A
routine chest X ray showed a round, well defined opacity in right
lung field. A chest CT scan confirmed the finding and also
described bronchiectasis. Patient had no respiratory symptoms. He
was prescribed with oral sulfasalazine and corticosteroids with
rapid improvement of intestinal symptoms as well as resolution of
the pulmonary opacity.
We describe the clinical presentation of a male newly diagnosed
with Crohn’s disease who was found to have an asymptomatic
pulmonary lesion on imaging studies. Pulmonary complications have
been previously described in inflamatory bowel disease being more
common in ulcerative colitis than in Crohn’s disease; these can
involve the lung parenchyma, the tracheobronchial tree, and the
pleura. The true prevalence and etiology of these lesions is
currently unknown and are not necessarily associated with bowel
disease activity. Abnormal pulmonary functions test have been
reported during inflammatory bowel disease exacerbations, and
although pulmonary findings can present with a variety of
symptoms, subclinical presentations have also been described.
Pulmonary manifestations are usually steoid-responsive, as was the
case in our patients.
|
|
